Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is

Oliver J Ziff1, Jasmine Harley2, Yiran Wang3

  • 1The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, WC1N 3BG London, UK; National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, WC1N 3BG London, UK.

Neuron
|July 22, 2023
PubMed

Insights

Amyotrophic lateral sclerosis (ALS) involves mislocalized proteins and RNA in motor neurons. Inhibiting VCP ATPase with ML240 partially restored normal localization, suggesting a potential therapeutic strategy for ALS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is linked to the mislocalization of TDP-43, an RNA-binding protein (RBP), between the nucleus and cytoplasm.
  • Evidence suggests broader mRNA and protein mislocalization occurs in ALS pathogenesis.

Purpose of the Study:

  • To investigate mRNA and protein localization in induced pluripotent stem cell-derived motor neurons (iPSMNs) from ALS patients with TARDBP and VCP mutations.
  • To explore the relationship between RBP mislocalization and mRNA redistribution in ALS.
  • To assess the therapeutic potential of VCP ATPase inhibition.

Main Methods:

  • Nucleocytoplasmic fractionation, RNA sequencing, and mass spectrometry were used to analyze mRNA and protein localization.
  • iPSMNs derived from ALS patients with TARDBP and VCP mutations were utilized.
  • Treatment with ML240, a VCP ATPase inhibitor, was applied to ALS mutant iPSMNs.

Main Results:

  • ALS mutant iPSMNs showed significant nucleocytoplasmic mRNA redistribution, RBP mislocalization, and altered splicing.
  • Mislocalized proteins demonstrated increased binding affinity to redistributed transcripts, indicating a connection between RBP and mRNA mislocalization.
  • ML240 treatment partially corrected mRNA and protein localization, altered the VCP interactome and lysosomal localization, and reduced oxidative stress and DNA damage.

Conclusions:

  • A strong link exists between RBP mislocalization and mRNA redistribution in ALS motor neurons.
  • VCP ATPase inhibition represents a promising therapeutic avenue for ALS treatment.

Related Concept Videos

Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...